SCHEMBL32388

SCHEMBL32388

c1ncc2sccc2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27747567 1.00 AXL (0.41)
SCHEMBL30711136 0.98 AXL (0.39)
Hydrochloric Acid SCHEMBL21803551 0.98 AXL (0.39)
Hydrazine SCHEMBL5897595 0.96 AXL (0.38)
Formaldehyde SCHEMBL28037402 0.94 AXL (0.37)
Pyrimidine SCHEMBL27714628 0.90 EGFR (0.38)
Piperazine SCHEMBL21803298 0.89 HTR2C (0.43)
Urea SCHEMBL28122176 0.89 AXL (0.34)
Pyridine SCHEMBL27578790 0.89 EGFR (0.37)
Acetic Acid SCHEMBL474261 0.87 ADORA2A (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6800 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260137819-A1 FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF RADIONETICS ONCOLOGY INC (US) 2026-05-21 US claimed
EP-3185329-B1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO LTD (KR) 2026-04-22 EP claimed
US-20260060970-A1 Use of a Therapeutic Agent with Phosphodiesterase-7 Inhibitory Activity for the Treatment and Prevention of Diseases Associated with Chronic Fatigue, Exhaustion and/or Exertional Intolerance MITODICURE GMBH (DE) 2026-03-05 US claimed
US-20260014090-A1 NANOPARTICLES FOR TARGETED NON-SURGICAL SPAYING AND NEUTERING UNIV GEORGIA (US) 2026-01-15 US claimed
US-20260007675-A1 TARGETING CHROMATIN REGULATORS INHIBITS LEUKEMOGENIC GENE EXPRESSION IN NPM1 MUTANT LEUKEMIA MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2026-01-08 US claimed
US-20250361239-A1 PROTEIN DEGRADERS AND USES THEREOF ZHUHAI YUFAN BIOTECHNOLOGIES CO LTD (CN) 2025-11-27 US claimed
EP-4643952-A2 TARGETING CHROMATIN REGULATORS FOR INHIBITING LEUKEMOGENIC GENE EXPRESSION IN NPM1 Memorial Sloan Kettering Cancer Center (US) 2025-11-05 EP claimed
EP-4598928-A1 FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF Radionetics Oncology, Inc. (US) 2025-08-13 EP claimed
WO-2025149628-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF NICOTINAMIDE N-METHYL TRANSFERASE ASTRAZENECA AB (SE) 2025-07-17 WO claimed
EP-3407884-B1 TARGETING CHROMATIN REGULATORS FOR INHIBITING LEUKEMOGENIC GENE EXPRESSION IN NPM1 MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2025-07-09 EP claimed
US-5264507-A Nonlinear optical systems BASF AKTIENGESELLSCHAFT (DE) 1993-11-23 US claimed
EP-0535490-A2 Polymers containing azo dyestuffs BASF Aktiengesellschaft (DE) 1993-04-07 EP claimed
EP-0365763-A1 Antiproliferative cyclic compounds AGOURON PHARMACEUTICALS, INC. (US) 1990-05-02 EP claimed
US-4898867-A ANTIDIABETIC AGENT TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1990-02-06 US claimed
EP-0335979-A1 THIENOPYRIMIDINE DERIVATIVES TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1989-10-11 EP claimed
EP-0071227-A1 Anti-leukemic beta-glycosyl C-nucleosides Sloan-Kettering Institute For Cancer Research (US) 1983-02-09 EP claimed
US-4196207-A Process for controlling eradicating or preventing infestations of animals by Ixodid ticks ICI AUSTRALIA LIMITED 1980-04-01 US claimed
US-4146716-A PLANT GROWTH REGULATORS, FUNGICIDES, BACTERICIDES, VIRICIDES, INSECTICIDES IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1979-03-27 US claimed
US-4001412-A HAS URICOSURIC ACTIVITY SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1977-01-04 US claimed
US-3957783-A URICOSURIC ACTIVITY SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-05-18 US claimed